Business Insights & Analytics - Undergrad Intern at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Healthcare, PharmaceuticalsIndustries

Requirements

Enrolled as a full-time Undergraduate student
Rising Senior (currently a Junior) with an expected graduation date between December 2026 – August 2027
Pursuing a Bachelor’s degree in Statistics, Mathematics, Computer Science, Economics, Finance, or a related field
Competence in at least one analytical Coding Language (R, SAS, Python, etc.)
Proficiency in Excel, Word, and PowerPoint
Competence in querying relational data
Broad awareness and working knowledge of statistical modeling (preferred)
Experience with prescription claims data (preferred)
Experience developing reports/dashboards in visualization applications (Tableau, Power-BI, R-Shiny, etc.) (preferred)
Strong analytical skills coupled with business acumen and the ability to think strategically and independently in an ambiguous environment
Excellent communication (written & verbal), interpersonal influencing skills and prioritization skills with attention to detail
High level of motivation and a strong desire to find creative solutions to challenging situations

Responsibilities

Develop understanding of Brand/Business Unit strategies, market dynamics, and data sources
Implement analytic solutions that provide data driven insights, help answer critical questions and meet business partner decision needs (project specifications will be provided by your Lilly Intern supervisor and will be aligned to intern’s interests and background)
Ensure analytics recommendations and key workstreams align to the broader organizational strategy
Proactively partner across BI&A for shared learning and to continue to elevate our analytics practice
Ensure compliance with all privacy and contractual obligations related to the use of data

Skills

Data Analysis

Analytics

Business Insights

Marketing Strategy

Data Privacy

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free